Pfizer Inc (NYSE:PFE)
| 44.26 Delayed Data As of Jan 26 |  +0.01 / +0.02%Today’s Change | 41.45 Today|||52-Week Range 56.32 | -13.62% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | Quarter 2 2019 | |||
| Assets | Cash | 3.6B | 1.2B | 1.9B | 1.8B | |
| Short Term Investment Cash | 848.0M | -2.4B | 793.0M | -182.0M | ||
| Cash & Short Term Investments | 17.2B | 18.8B | 11.6B | 12.9B | ||
| Receivables | Receivables | 10.0B | 8.0B | 9.6B | 9.8B | |
| Inventories | Inventories | 8.2B | 7.5B | 8.0B | 8.2B | |
| Current Assets | Other Current Assets | 6.1B | 15.6B | 16.0B | 16.1B | |
| Current Assets | 41.6B | 49.9B | 45.3B | 47.1B | ||
| Total Assets | Property, Plant and Equipment - Gross | 31.1B | 30.0B | 30.9B | 31.2B | |
| Depreciation | -17.1B | -16.6B | -16.2B | -16.4B | ||
| Intangible Assets | 100.9B | 88.6B | 87.5B | 86.4B | ||
| Other Assets | 103.9B | 91.4B | 90.6B | 89.5B | ||
| Total Assets | 167.8B | 159.4B | 155.4B | 156.2B | ||
| Liabilities | Accounts Payable | 4.3B | 4.7B | 4.2B | 4.0B | |
| Short Term Debt | 7.4B | 8.8B | 9.7B | 10.8B | ||
| Accrued Expenses | 4.3B | 4.6B | 4.6B | 4.5B | ||
| Other Current Liabilities | 10.5B | 12.6B | 12.0B | 11.9B | ||
| Other Liabilities | 29.0B | 31.9B | 29.4B | 32.0B | ||
| Total Liabilities | Long Term Debt | 33.7B | 32.9B | 36.8B | 37.2B | |
| Deferred Taxes | -3.6B | -1.8B | -1.6B | -1.2B | ||
| Other Liabilities | 6.4B | 5.9B | 5.3B | 5.2B | ||
| Total Liabilities | 96.2B | 95.7B | 96.3B | 96.3B | ||
| Equity | Minority Interest | -8.0M | -11.0M | -6.0M | -10.0M | |
| Preferred Stock | 20.0M | 19.0M | 19.0M | 18.0M | ||
| Common Equity | 71.3B | 63.4B | 58.8B | 59.6B | ||
| Total Shareholder Equity | 71.3B | 63.4B | 58.8B | 59.6B | ||
| Share Information | Common Shares Outstanding | 5.8B | 5.7B | 5.6B | 5.6B | |
| Addtl. Info. | No data currently available for this section. | |||||